Zyprexa Relprevv (Olanzapine Pamoate): Drug Safety Communication - FDA Investigating Two Deaths Following Injection

Two patients died 3-4 days after receiving an appropriate dose of the drug. Posted 06/18/2013

 
comments powered by Disqus